• Efficacy and safety profile of COVID-19 vaccine in cancer patients: a prospective, multicenter cohort study
  Author: Yasin et al.
  Date:  27-Jan-22
  Journal: Future Oncology
   
• Humoral and cellular immunogenicity of SARS-CoV-2 vaccines in chronic lymphocytic leukemia: a prospective cohort study
  Author: Haydu et al.
  Date:  24-Jan-22
  Journal: Blood Advances
   
• Investigation of anxiety sensitivity levels of cancer patients in terms of COVID-19 vaccine: a cross-sectional study
  Author: Iscan et al.
  Date:  24-Jan-22
  Journal: Supportive Care in Cancer 
   
• Protocol for SARS-CoV-2 post-vaccine surveillance study in Australian adults and children with cancer: an observational study of safety and serological and immunological response to SARS-CoV-2 vaccination (SerOzNET)
  Author: Body et al.
  Date:  20-Jan-22
  Journal: BMC Infectious Diseases
   
• COVID-19 vaccination rates, intent, and hesitancy in patients with solid organ and blood cancers: A multicenter study
  Author: Nguyen et al.
  Date:  18-Jan-22
  Journal: Asia-Pacific Journal of Clinical Oncology
   
• Safety of the BNT162b2 mRNA COVID-19 vaccine in oncologic patients undergoing numerous cancer treatment options: A retrospective single-center study
  Author: Waleed et al.
  Date:  14-Jan-22
  Journal: Medicine
   
• Immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in patients with primary brain tumors: a prospective cohort study
  Author: Massarweh et al.
  Date:  12-Jan-22
  Journal: Journal of Neuro-Oncology
   
• Cancer and COVID-19: On the Quest for Effective Vaccines
  Author: Kwok et al.
  Date:  12-Jan-22
  Journal: Blood Cancer Discovery
   
• The antibody response of haematological malignancies to COVID-19 infection and vaccination
  Author: Seebacher et al.
  Date:  11-Jan-22
  Journal: British Journal of Cancer
   
• Acute axillary lymphadenopathy detected shortly after COVID-19 vaccination found to be due to newly diagnosed metastatic melanoma
  Author: Gullotti et al.
  Date:  10-Jan-22
  Journal: Radiology Case Reports
   
• COVID-19 vaccine response in patients with hematologic malignancy: a systematic review and meta-analysis
  Author: Gong et al.
  Date:  10-Jan-22
  Journal: American Journal of Hematology
   
• Impaired neutralisation of SARS-CoV-2 delta variant in vaccinated patients with B cell chronic lymphocytic leukaemia
  Author: Parry et al.
  Date:  09-Jan-22
  Journal: Journal of Hematology & Oncology
   
• SARS-CoV-2 Antibody Response to 2 or 3 Doses of the BNT162b2 Vaccine in Patients Treated With Anticancer Agents
  Author: Fenioux et al.
  Date:  07-Jan-22
  Journal: JAMA Oncology
   
• Antibody response to SARS-CoV-2 mRNA vaccine in lung cancer patients: Reactivity to vaccine antigen and variants of concern
  Author: Valanparambil et al.
  Date:  04-Jan-22
  Journal: medRxiv
   
• Effect of Coronavirus Disease 2019 Vaccine-Related Lymphadenopathy on Lung Cancer Treatment
  Author: Masago et al.
  Date:  01-Jan-22
  Journal: Journal of Thoracic Oncology
   
• Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in Patients With Cancer: The CANVAX Cohort Study
  Author: Naranbhai et al.
  Date:  01-Jan-22
  Journal: Journal of Clinical Oncology
   
• Letter comments on: Efficacy and safety of BNT162b2 vaccination in solid cancer patients receiving anti-cancer therapy - A single-centre prospective study: Interaction between lymphopenia and anti-SARS-CoV-2 antibodies after two injections of the Pfizer-BioNTech vaccine in patients with cancers treated by chemotherapy or immunotherapy
  Author: Sekkate et al.
  Date:  01-Jan-22
  Journal: European Journal of Cancer
   
• Immunogenicity and risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection after Coronavirus Disease 2019 (COVID-19) vaccination in patients with cancer: a systematic review and meta-analysis
  Author: Beccerril-Gaitan et al.
  Date:  01-Jan-22
  Journal: European Journal of Cancer
   
• COVID-19 mRNA booster vaccines elicit strong protection against SARS-CoV-2 Omicron variant in patients with cancer
  Author: Zeng et al.
  Date:  30-Dec-21
  Journal: Cancer Cell
   
• Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer
  Author: Fendler et al.
  Date:  29-Dec-21
  Journal: Cancer Cell
   
• Antibody Titers Before and After a Third Dose of the SARS-CoV-2 BNT162b2 Vaccine in Cancer patients
  Author: Debie et al.
  Date:  29-Dec-21
  Journal: European Journal of Cancer
   
• Safety of SARS-CoV-2 vaccines in patients with chronic myeloid leukemia
  Author: Yang et al.
  Date:  29-Dec-21
  Journal: Chinese Medical Journal
   
• Short-term safety of an anti-severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine for patients with advanced lung cancer treated with anticancer drugs: A multicenter, prospective, observational study
  Author: Tamura et al.
  Date:  28-Dec-21
  Journal: Thoracic Cancer
   
• COVID-19 vaccine failure in chronic lymphocytic leukaemia and monoclonal B-lymphocytosis; humoural and cellular immunity
  Author: Shen et al.
  Date:  28-Dec-21
  Journal: British Journal of Haematology
   
• Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with multiple myeloma
  Author: Greenberg et al.
  Date:  27-Dec-21
  Journal: BMC Cancer
   
• Humoral and cellular immunogenicity two months after SARS-CoV-2 messenger RNA vaccines in patients with cancer
  Author: Bordry et al.
  Date:  24-Dec-21
  Journal: iScience
   
• COVID-19 Vaccination and Breakthrough Infections in Patients with Cancer
  Author: Schmidt et al.
  Date:  24-Dec-21
  Journal: Annals of Oncology
   
• Axillary Lymphadenopathy After COVID-19 Vaccination in a Woman With Breast Cancer
  Author: Lam et al.
  Date: 23-Dec-21
  Journal: JAMA Clinical Challenge
   
• Immune-related adverse events of COVID-19 vaccination in skin cancer patients receiving immune-checkpoint inhibitor treatment
  Author: Strobel et al.
  Date:  23-Dec-21
  Journal: Cancer immunology, immunotherapy
   
• Immunogenicity and safety of BNT162b2 mRNA vaccine booster in actively treated patients with cancer
  Author: Ligumsky et al.
  Date:  23-Dec-21
  Journal: The Lancet
   
• Impaired Immune Response to COVID-19 Vaccination in Patients with B-Cell Malignancies after CD19 CART Cell Therapy
  Author: Dahiya et al.
  Date:  23-Dec-21
  Journal: Blood Advances
   
• Impaired seroconversion after SARS-CoV-2 mRNA vaccines in patients with solid tumours receiving anticancer treatment
  Author: Amatu et al.
  Date:  22-Dec-21
  Journal: European Journal of Cancer
   
• SARS-CoV-2 specific cellular response following COVID-19 vaccination in patients with chronic lymphocytic leukemia
  Author: Mellinghoff et al.
  Date:  22-Dec-21
  Journal: Nature Leukemia
   
• Cancer Patients and COVID-19 Vaccination
  Author: Kieber-Emmons T.
  Date:  21-Dec-21
  Journal: Monoclonal Antibodies in Immunodiagnosis and Immunotherapy
   
• Booster effect after SARS-CoV-2 vaccination in hematological immunocompromised patients with prior COVID-19
  Author: Pinana et al.
  Date:  21-Dec-21
  Journal: Blood Advances
   
• Antibody response after vaccination against SARS-CoV-2 in adults with haematological malignancies: A systematic review and meta-analysis
  Author: Gagelmann et al.
  Date:  16-Dec-21
  Journal: Haematologica
   
• Supraclavicular lymphadenopathy after COVID-19 vaccination
  Author: Larkin et al.
  Date:  16-Dec-21
  Journal: Pediatric Blood & Cancer
   
• Third dose of anti-SARS-CoV-2 vaccine for patients with cancer: Should humoral responses be monitored? A position paper
  Author: Barrière et al.
  Date:  15-Dec-21
  Journal: European Journal of Cancer
   
• Humoral and cellular immune responses to the SARS-CoV-2 BNT162b2 vaccine among a cohort of solid organ transplant recipients and healthy controls
  Author: Yanis et al.
  Date:  14-Dec-21
  Journal: Transplant Infectious Disease
   
• SARS-CoV-2 infection in fully vaccinated patients with multiple myeloma
  Author: Sgherza et al.
  Date:  14-Dec-21
  Journal: Blood Cancer Journal
   
• Immune biomarkers to predict SARS-CoV-2 vaccine effectiveness in patients with hematological malignancies
  Author: Tamariz-Amador et al.
  Date:  14-Dec-21
  Journal: Blood Cancer Journal
   
• Reasons to Consider the COVID-19 Vaccination Status of Patients With Cancer When Analyzing Their COVID-19 Outcomes
  Author: Takada et al.
  Date:  10-Dec-21
  Journal: Journal of Clinical Oncology
   
• Attenuated response to SARS-CoV-2 vaccine in patients with asymptomatic precursor stages of multiple myeloma and Waldenstrom macroglobulinemia
  Author: Konishi et al.
  Date:  09-Dec-21
  Journal: Cancer Cell
   
• The outcome of COVID-19 in patients with hematological malignancy
  Author: Tığlıoğlu et al.
  Date:  09-Dec-21
  Journal: memo - Magazine of European Medical Oncology
   
• Six-months immunogenicity of COVID-19 mRNA-BNT162b2 vaccine in actively treated cancer patients: Updated results of the Vax-On study
  Author: Nelli et al.
  Date:  09-Dec-21
  Journal: Annals of Oncology
   
• Efficacy and safety of heterologous booster vaccination with Ad26.COV2.S after BNT162b2 mRNA COVID-19 vaccine in haemato-oncological patients with no antibody response
  Author: Reimann et al.
  Date:  06-Dec-21
  Journal: British Journal of Haematology
   
• Cellular and humoral Immune response to mRNA COVID-19 vaccination in subjects with chronic lymphocytic leukemia
  Author: Lyski et al.
  Date:  06-Dec-21
  Journal: Blood Advances
   
• Absolute lymphocyte count after COVID-19 vaccination is associated with vaccine-induced hypermetabolic lymph nodes on 18F-FDG PET/CT: a focus in breast cancer care
  Author: Seban et al.
  Date:  02-Dec-21
  Journal: Journal of Nuclear Medicine
   
• Association of COVID-19 Vaccination With SARS-CoV-2 Infection in Patients With Cancer: A US Nationwide Veterans Affairs Study
  Author: Tsu-Yu-Wu et al.
  Date:  02-Dec-21
  Journal: JAMA Oncology
   
• Neutralizing Antibody Testing in Patients With Multiple Myeloma Following COVID-19 Vaccination
  Author: Terpos et al.
  Date:  02-Dec-21
  Journal: JAMA Oncology
   
• Immunogenicity of COVID-19 vaccines in patients with hematological malignancy: A systematic review and meta-analysis
  Author: Teh et al.
  Date:  01-Dec-21
  Journal: Blood Advances
   
• Impact of corona-phobia on attitudes and acceptance towards COVID-19 vaccine among cancer patients: A single-center study
  Author: Erdem and Karaman.
  Date:  01-Dec-21
  Journal: Future Medicine
   
• The prioritation and gap of preoperative COVID-19 vaccination in cancer surgery of the breast, head and neck, and skin: A cohort study of 367 patients in an Indonesian hospital
  Author: Anwar et al.
  Date:  01-Dec-21
  Journal: Annals of Medicine and Surgery
   
• Humoral response to mRNA anti-COVID-19 vaccines BNT162b2 and mRNA-1273 in patients with chronic lymphocytic leukemia
  Author: Bagacean et al.
  Date:  29-Nov-21
  Journal: Blood Advances
   
• Cellular and humoral immunogenicity of the mRNA-1273 SARS-CoV-2 vaccine in patients with hematologic malignancies
  Author: Jimenez et al.
  Date:  29-Nov-21
  Journal: Blood Advances
   
• COVID-19 Vaccination Acceptance and Its Associated Factors among Cancer Patients in Tunisia
  Author: Khiari et al.
  Date:  27-Nov-21
  Journal: Asian Pacific Journal of Cancer Prevention
   
• Heterogeneous immunogenicity of SARS-CoV-2 vaccines in cancer patients receiving radiotherapy
  Author:  Bowes et al.
  Date:  25-Nov-21
  Journal: Radiotherapy & Oncology
   
• Letter of response to comment on: Efficacy and safety of BNT162b2 vaccination in solid cancer patients receiving anti-cancer therapy - A single centre prospective study
  Author:  Shacham-Shmueli et al.
  Date:  25-Nov-21
  Journal: European Journal of Cancer
   
• Assessment of Response to a Third Dose of the SARS-CoV-2 BNT162b2 mRNA Vaccine in Patients With Solid Tumors Undergoing Active Treatment
  Author:  Rottenberg et al.
  Date:  23-Nov-21
  Journal: JAMA Oncology
   
• Safety of COVID-19 mRNA Vaccines in Patients with Cancer Enrolled in Early-Phase Clinical Trials
  Author:  Aliaga et al.
  Date:  20-Nov-21
  Journal: mdpi Cancers
   
• COVID-19 vaccination and cancer immunotherapy: should they stick together?
  Author:  Brest et al.
  Date:  19-Nov-21
  Journal: British Journal of Cancer
   
• SARS-CoV-2 vaccine acceptability among caregivers of childhood cancer survivors
  Author:  Wimberly et al.
  Date:  17-Nov-21
  Journal: Pediatric Blood & Cancer
   
• Efficacy of Severe Acute Respiratory Syndrome Coronavirus-2 Vaccine in Patients With Thoracic Cancer: A Prospective Study Supporting a Third Dose in Patients With Minimal Serologic Response After Two Vaccine Doses
  Author:  Gounant et al.
  Date:  16-Nov-21
  Journal: Journal of Thoracic Oncology
   
• Efficacy of booster doses in augmenting waning immune responses to COVID-19 vaccine in patients with cancer
  Author:  Shapiro et al.
  Date:  16-Nov-21
  Journal: Cancer Cell
   
• How to Provide the Needed Protection from COVID-19 to Patients with Hematologic Malignancies
  Author:  Ribas et al.
  Date: 13-Nov-21
  Journal: Blood Cancer Discovery
   
• Safety and preliminary efficacy of the Gam-COVID-Vac vaccine and outcomes of SARS-CoV-2 infection in Russian patients with genitourinary malignancies
  Author:  Tsimafeyeu et al.
  Date:  13-Nov-21
  Journal: Journal of Hematology & Oncology
   
• COVID-19 vaccines and cancer patients: acceptance, attitudes and safety
  Author:  Brko et al.
  Date:  11-Nov-21
  Journal: JBUON
   
• Vaccine third dose and cancer patients: necessity or luxury?
  Author:  Pappas et al.
  Date:  10-Nov-21
  Journal: ESMO Open
   
• Longitudinal SARS-CoV-2 mRNA vaccine-induced humoral immune responses in cancer patients
  Author:  Figueiredo et al.
  Date:  10-Nov-21
  Journal: Cancer Research
   
• Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in Patients With Cancer: The CANVAX Cohort Study
  Author:  Naranbhai et al.
  Date:  09-Nov-21
  Journal: Journal of Clinical Oncology
   
• mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non-inferiority trial
  Author:  Oosting et al.
  Date:  09-Nov-21
  Journal: The Lancet
   
• The mRNA COVID-19 vaccine in patients with cancer receiving checkpoint inhibitor therapy: what we know and what we don't
  Author:  Malek et al.
  Date:  08-Nov-21
  Journal: Immunotherapy
   
• COVID-19 in vaccinated adult patients with hematological malignancies. Preliminary results from EPICOVIDEHA
  Author:  Pagano et al.
  Date:  08-Nov-21
  Journal: Blood
   
• Serum antibody response in patients with philadelphia-chromosome positive or negative myeloproliferative neoplasms following vaccination with SARS-CoV-2 spike protein messenger RNA (mRNA) vaccines
  Author:  Kozak et al.
  Date:  05-Nov-21
  Journal: Nature Leukemia
   
• Knowledge and Proportion of COVID-19 Vaccination and Associated Factors Among Cancer Patients Attending Public Hospitals of Addis Ababa, Ethiopia, 2021: A Multicenter Study
  Author:  Admasu F.
  Date:  04-Nov-21
  Journal: Infection and Drug Resistance
   
• Antibody Responses to COVID-19 Vaccination in Cancer: A Systematic Review
  Author:  Guven et al.
  Date:  04-Nov-21
  Journal: Frontiers in Oncology
   
• Case Report: Vaccine-induced Immune Thrombotic Thrombocytopenia in Pancreatic Cancer Patient After Vaccination with Messenger RNA-1273
  Author:  Hsu-Su et al.
  Date:  01-Nov-21
  Journal: Frontiers in Medicine
   
• Poor neutralizing antibody responses in 106 patients with WM after vaccination against SARS-CoV-2: a prospective study
  Author:  Gavriatopoulou et al.
  Date:  01-Nov-21
  Journal: Blood Advances
   
• Low Serological Prevalence of SARS-CoV-2 Antibodies in Cancer Patients at a German University Oncology Center
  Author:  Overheu et al.
  Date:  01-Nov-21
  Journal: Oncology Research and Treatment
   
• COVID-19 vaccines in adult cancer patients with solid tumours undergoing active treatment: Seropositivity and safety. A prospective observational study in Italy
  Author:  Cavanna et al.
  Date:  01-Nov-21
  Journal: European Journal of Cancer
   
• Efficacy and safety of BNT162b2 vaccination in patients with solid cancer receiving anticancer therapy – a single centre prospective study
  Author:  Shmueli et al.
  Date:  01-Nov-21
  Journal: European Journal of Cancer
   
• Lymphadenopathy After the Third Covid-19 Vaccine
  Author:  Özütemiz et al.
  Date:  30-Oct-21
  Journal: Current Problems in Cancer: Case Reports
   
• COVID-19 vaccination in patients with breast cancer and gynecological malignancies: A German perspective
  Author:  Forster et al.
  Date:  29-Oct-21
  Journal: The Breast
   
• COVID-19 vaccination in patients with multiple myeloma: a consensus of the European Myeloma Network
  Author:  Ludwig et al.
  Date:  28-Oct-21
  Journal: The Lancet Haematology
   
• Seroconversion rate after vaccination against COVID-19 in cancer patients - a systematic review
  Author:  Corti et al.
  Date:  27-Oct-21
  Journal: Annals of Oncology
   
• Letter comments on: Efficacy and Safety of BNT162b2 Vaccination in Solid Cancer Patients Receiving Anti-Cancer Therapy - a Single Center Prospective Study
  Author:  Sekkate et al.
  Date:  27-Oct-21
  Journal: European Journal of Cancer
   
• Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study
  Author:  Fendler et al.
  Date:  27-Oct-21
  Journal: Nature Cancer
   
• COVID-19 Vaccine-Related Axillary and Cervical Lymphadenopathy in Patients with Current or Prior Breast Cancer and Other Malignancies: Cross-Sectional Imaging Findings on MRI, CT, and PET-CT
  Author:  Lane et al.
  Date:  26-Oct-21
  Journal: Korean Journal of Radiology
   
• Immunogenicity and Risk of SARS-CoV-2 Infection after COVID-19 Vaccination in Patients with Cancer: A Systematic Review and Meta-Analysis
  Author:  Gaitan et al.
  Date:  26-Oct-21
  Journal: European Journal of Cancer
   
• COVID-19 Vaccine-Related Axillary Lymphadenopathy in Breast Cancer Patients: Case Series with a Review of Literature
  Author:  Lim et al.
  Date:  26-Oct-21
  Journal: Seminars in Oncology
   
• Evaluation of COVID-19 vaccine response in cancer patients: an interim analysis
  Author:  Tran et al.
  Date:  25-Oct-21
  Journal: European Journal of Cancer
   
• Impaired Neutralizing Antibody Response to COVID-19 mRNA Vaccines in Cancer Patients
  Author:  Zeng et al.
  Date:  21-Oct-21
  Journal: medRxiv
   
• SARS-CoV-2 vaccine uptake, perspectives and adverse reactions following vaccination in patients with cancer undergoing treatment
  Author:  Figureiredo et al.
  Date:  20-Oct-21
  Journal: Annals of Oncology
   
• COVID-19 vaccine hesitancy among Tunisian cancer patients in the Salah Azaeiz Institute of Cancer
  Author:  Cherif et al.
  Date:  20-Oct-21
  Journal: European Journal of Public Health
   
• Assessment of COVID-19 vaccine literacy among cancer patients: A cross sectional Tunisian study
  Author:  Cherif et al.
  Date:  20-Oct-21
  Journal: European Journal of Public Health
   
• Humoral and cellular responses after COVID-19 vaccination in anti-CD20 treated lymphoma patients
  Author:  Liebers et al.
  Date:  20-Oct-21
  Journal: Blood
   
• Spanish Society of Hematology and Hemotherapy expert consensus opinion for SARS-CoV-2 vaccination in onco-hematological patients
  Author:  Piñana et al.
  Date:  20-Oct-21
  Journal: Leukemia & Lymphoma
   
• Variable cellular responses to SARS-CoV-2 in fully vaccinated patients with multiple myeloma
  Author:  Aleman et al.
  Date: 18-Oct-21
  Journal: Cancer Cell
   
• COVID-19 vaccinations for patients with cancer: many remain unvaccinated despite having priority in the vaccine rollout
  Author:  Body et al.
  Date:  18-Oct-21
  Journal: Internal Medicine Journal
   
• Effectiveness of the BNT162b2mRNA Covid-19 vaccine in patients with hematological neoplasms
  Author:  Mittelman et al.
  Date:  18-Oct-21
  Journal: Blood
   
• BNT162b2 mRNA COVID-19 vaccination in immunocompromised patients: A prospective cohort study
  Author:  Rahav et al.
  Date:  17-Oct-21
  Journal: The Lancet
   
• A sigh of relief: vaccine-associated hypermetabolic lymphadenopathy following the third COVID-19 vaccine dose is short in duration and uncommonly interferes with the interpretation of [18F]FDG PET-CT studies performed in oncologic patients
  Author: Cohen et al.
  Date:  15-Oct-21
  Journal: European Journal of Nuclear Medicine and Molecular Imaging
   
• T-cell immune response after mRNA SARS-CoV-2 vaccines is frequently detected also in the absence of seroconversion in patients with lymphoid malignancies
  Author:  Marasco et al.
  Date:  14-Oct-21
  Journal: British Journal of Haematology
   
• Response to COVID-19 mRNA vaccination in multiple myeloma is conserved but impaired compared to controls
  Author:  Bitoun et al.
  Date:  13-Oct-21
  Journal: Journal of Hematology & Oncology
   
• Immunological Response to COVID-19 Vaccination in Ovarian Cancer Patients Receiving PARP Inhibitors
  Author:  McKenzie et al.
  Date:  11-Oct-21
  Journal: Cancer Cell
   
• COVID-19 vaccination in pediatric cancer patients: A high priority
  Author:  Charla et al
  Date:  11-Oct-21
  Journal: Pediatric Blood & Cancer
   
• Regional lymphadenopathy following COVID-19 vaccination: Literature review and considerations for patient management in breast cancer care
  Author:  Garreffa et al.
  Date:  10-Oct-21
  Journal: European Journal of Cancer
   
• Immunological Response to COVID-19 Vaccination in Ovarian Cancer Patients Receiving PARP Inhibitors
  Author:  Liontos et al.
  Date:  08-Oct-21
  Journal: Vaccines
   
• COVID-19 vaccine hesitancy in India
  Author:  Dani et al.
  Date:  08-Oct-21
  Journal: Cancer Research, Statistics and Treatment
   
• Reasons to consider the COVID-19 vaccination status of patients with cancer when analyzing their COVID-19 outcomes
  Author:  Takada et al.
  Date:  08-Oct-21
  Journal: Journal of Clinical Oncology
   
• Efficacy of COVID-19 vaccines in immunocompromised patients: A systematic review and meta-analysis
  Author:  Lee et al.
  Date:  01-Oct-21
  Journal: medRxiv
   
• Humoral immune response in hematooncological patients and health care workers who received SARS-CoV-2 vaccinations
  Author:  Nair et al.
  Date:  30-Sep-21
  Journal: JAMA Oncology
   
• Immune responses to two and three doses of the BNT162b2 mRNA vaccine in adults with solid tumors
  Author:  Shroff et al.
  Date:  30-Sep-21
  Journal: Nature Medicine
   
• Letter to Editor, Re: The first report on Covid-19 vaccine refusal by cancer patients in Italy: early data from a single-institute survey: Educational Webinar about COVID-19 Vaccines in Oncological Patients: A Promising Strategy to Tackle COVID-19 Vaccine Hesitancy
  Author:  Villarreal-Garza et al.
  Date:  29-Sep-21
  Journal: European Journal of Cancer
   
• Immunogenicity and safety of COVID-19 vaccine BNT162b2 for patients with solid cancer: a large cohort prospective study from a single institution
  Author:  Di Noia et al.
  Date:  28-Sep-21
  Journal: Clinical Cancer Research
   
• Serologic response to COVID-19 infection and/or vaccine in cancer patients on active treatment
  Author:  Grinsphun et al.
  Date:  26-Sep-21
  Journal: ESMO Open
   
• Acceptance of coronavirus disease 2019 vaccination by cancer patients in Cyprus: A cross-sectional study
  Author:  Roupa et al.
  Date:  25-Sep-21
  Journal: Journal of Oncology Pharmacy Practice
   
• Low seropositivity and suboptimal neutralisation rates in patients fully vaccinated against COVID-19 with B-cell malignancies
  Author:  Fox et al.
  Date:  21-Sep-21
  Journal: British Journal of Haematology
   
• COVID-19 vaccines in cancer patients. Seropositivity and safety. Systematic review and meta-analysis
  Author:  Cavanna et al.
  Date:  20-Sep-21
  Journal: Vaccines
   
• Effects of active cancer treatment on safety and immunogenicity of COVID-19 mRNA-BNT162b2 vaccine: Preliminary results from the prospective observational Vax-On study
  Author:  Nelli et al.
  Date:  19-Sep-21
  Journal: Annals of Oncology
   
• SARS-CoV-2 vaccination in patients with solid tumors or hematological malignancies: Is the pandemic over for fully vaccinated patients?
  Author: Zojer N.
  Date:  16-Sep-21
  Journal: memo - Magazine of European Medical Oncology
   
• Responses to SARS-CoV-2 vaccination in patients with cancer (ReCOVer Study): A prospective cohort study of the Hellenic Cooperative Oncology Group
  Author:  Linardou et al.
  Date:  15-Sep-21
  Journal: cancers
   
• COVID-19 vaccination for children with cancer
  Author:  Kotecha R.
  Date:  14-Sep-21
  Journal: Pediatric Blood & Cancer
   
• Disease and therapy-specific impact on humoral immune responses to COVID-19 vaccination in hematologic malignancies
  Author:  Chung et al.
  Date:  13-Sep-21
  Journal: Blood Cancer Discovery
   
• Cancer or COVID-19? A review of recommendations for COVID-19 vaccination in cancer patients
  Author:  Gundavda and Gundavda.
  Date:  13-Sep-21
  Journal: Current Treatment Options in Oncology
   
• Efficacy and safety of BNT162b2 vaccination in patients with solid cancer receiving anticancer therapy – a single centre prospective study
  Author:  Shmueli et al.
  Date:  08-Sep-21
  Journal: European Journal of Cancer
   
• Brief report axillary lymphadenopathy after COVID-19 vaccinations in patients with thoracic malignancy: Incidence, predisposing factors, and imaging characteristics
  Author:  Nishino et al.
  Date:  07-Sep-21
  Journal: Journal of Thoracic Oncology
   
• Anti-spike antibody response to SARS-CoV-2 booster vaccination in patients with B cell-derived hematologic malignancies
  Author:  Greenberger et al.
  Date:  07-Sep-21
  Journal: Cancer Cell
   
• Poor neutralizing antibody responses in 132 Patients with CLL, NHL and HL after vaccination against SARS-CoV-2: A prospective study
  Author:  Terpos et al.
  Date:  06-Sep-21
  Journal: cancers
   
• The 12-week kinetics of anti-SARS-CoV-2 antibodies in different haematological cancers after vaccination with BNT162b2
  Author:  Marchesi et al.
  Date:  06-Sep-21
  Journal: British Journal of Haematology
   
• Six month efficacy and toxicity profile of BNT162b2 vaccine in cancer patients with solid tumors
  Author: Waldhorn et al.
  Date:  02-Sep-21
  Journal: Cancer Discovery
   
• COVID-19 vaccines in adult cancer patients with solid tumors undergoing active treatment: seropositivity and safety. A prospective observational study in Italy
  Author:  Cavanna et al.
  Date:  01-Sep-21
  Journal: European Journal of Cancer
   
• COVID-19 vaccination: Evaluation of risk for protection failure in chronic lymphocytic leukemia patients
  Author:  Del Poeta et al.
  Date:  30-Aug-21
  Journal: Hematological Oncology
   
• SARS-CoV-2 neutralizing antibodies after first vaccination dose in breast cancer patients receiving CDK4/6 inhibitors
  Author:  Zagouri et al.
  Date:  28-Aug-21
  Journal: The Breast
   
• Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine among actively treated cancer patients
  Author:  Ligumsky et al.
  Date:  28-Aug-21
  Journal: JNCI: Journal of the National Cancer Institute
   
• COVID-19 vaccine among actively-treated people with cancer: A glimpse into the known unknowns?
  Author:  Thakkar et al.
  Date:  28-Aug-21
  Journal: JNCI: Journal of the National Cancer Institute
   
• Evaluation of antibody responses to COVID-19 vaccines among solid tumor and hematologic patients
  Author:  Singer et al.
  Date:  26-Aug-21
  Journal: cancers
   
• Examining the immunological effects of COVID-19 vaccination in patients with conditions potentially leading to diminished immune response capacity – The OCTAVE Trial
  Author:  Kearns et al.
  Date:  23-Aug-21
  Journal: The Lancet
   
• COVID-19 vaccination mimicking lymph-node progression in a patient with melanoma
  Author:  Indini et al.
  Date:  23-Aug-21
  Journal: Melanoma Research
   
• Australia and New Zealand Transplant and Cellular Therapies COVID-19 vaccination consensus position statement
  Author:  Hamad et al.
  Date:  22-Aug-21
  Journal: Internal Medicine Journal
   
• South Asian Declaration—Consensus guidelines for COVID-19 vaccination in cancer patients
  Author:  Thirumalairaj et al.
  Date:  20-Aug-21
  Journal: South Asian Journal of Cancer
   
• Axillary lymphadenopathy at the time of COVID-19 vaccination: ten recommendations from the European Society of Breast Imaging (EUSOBI)
  Author:  Schiaffino et al.
  Date:  20-Aug-21
  Journal: Insights Imaging
   
• COVID-19 vaccination for endocrine patients: A position statement from the Korean Endocrine Society
  Author:  Ku et al.
  Date:  17-Aug-21
  Journal: Endocrinology and Metabolism
   
• Safety of administration of BNT162b2 mRNA (Pfizer-BioNTech) COVID-19 vaccine in youths and young adults with a history of acute lymphoblastic leukemia and allergy to PEG-asparaginase
  Author:  Mark et al.
  Date:  16-Aug-21
  Journal: Pediatric Blood & Cancer
   
• Serologic response to mRNA COVID-19 vaccination in lymphoma patients
  Author:  Jurgens et al.
  Date:  14-Aug-21
  Journal: American Journal of Hematology
   
• Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with B-cell non-Hodgkin lymphoma
  Author:  Perry et al.
  Date:  13-Aug-21
  Journal: Blood Advances
   
• Activity of mRNA COVID-19 vaccines in patients with lymphoid malignancies
  Author:  Crombie et al.
  Date:  13-Aug-21
  Journal: Blood Advances
   
• Antibody response to COVID-19 vaccination in adults with hematologic malignant disease
  Author:  Ollila et al.
  Date:  11-Aug-21
  Journal: JAMA Oncology
   
• Durability of response to SARS-CoV-2 BNT162b2 vaccination in patients on active anticancer treatment
  Author:  Eliakim-Raz et al.
  Date:  11-Aug-21
  Journal: JAMA Oncology
   
• Acute tolerance of Moderna mRNA-1273 vaccine against COVID-19 in patients with cancer treated with radiotherapy
  Author:  Scoccianti et al.
  Date:  11-Aug-21
  Journal: The Lancet Oncology
   
• Weak immunogenicity of SARS-CoV-2 vaccine in patients with hematologic malignancies
  Author:  Malard et al.
  Date:  10-Aug-21
  Journal: Blood Cancer Journal
   
• Safety and immunogenicity following 2 doses of BNT162b2 COVID-19 vaccine in an early phase oncology trial center population
  Author:  Malissen et al.
  Date:  10-Aug-21
  Journal: European Journal of Cancer
   
• Immune responses to COVID-19 vaccines in patients with cancer: Promising results and a note of caution
  Author:  Griffiths and Segal.
  Date:  09-Aug-21
  Journal: Cancer Cell
   
• Managing the risk of delayed breast cancer screening versus COVID-19 vaccination associated axillary lymphadenopathy
  Author:  Garver K.
  Date:  08-Aug-21
  Journal: Academic Radiology
   
• SARS-CoV-2 vaccination and cancer therapy: A successful but mindful mix
  Author:  Di Giacomo et al.
  Date:  04-Aug-21
  Journal: European Journal of Cancer
   
• Immunogenicity and safety of the CoronaVac vaccine in patients with cancer receiving active systemic therapy
  Author:  Karacin et al.
  Date:  03-Aug-21
  Journal: Future Oncology
   
• COVID-19 and the cancer patient
  Author:  Ianniello N.
  Date:  02-Aug-21
  Journal: American Journal of Biomedical Science & Research
   
• The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment
  Author:  Terpos et al.
  Date:  02-Aug-21
  Journal: Blood Cancer Journal
   
• Perceptions of the COVID-19 vaccine among patients with cancer: A single-institution survey
  Author:  Moujaess et al.
  Date:  02-Aug-21
  Journal: Future Oncology
   
• Reduced SARS-COV-2 infection and death after two doses of COViD-19 vaccines in a series of 1503 cancer patients
  Author:  Heudel et al.
  Date:  02-Aug-21
  Journal: Annals of Oncology
   
• Response to mRNA vaccination for COVID-19 among patients with multiple myeloma
  Author:  Stampfer et al.
  Date:  29-Jul-21
  Journal: Leukemia
   
• Safety and efficacy of BNT162b mRNA Covid19 Vaccine in patients with chronic lymphocytic leukemia
  Author:  Benjamini et al.
  Date:  29-Jul-21
  Journal: Haematologica
   
• COVID-19 mRNA vaccines and immune-related adverse events in cancer patients treated with immune checkpoint inhibitors
  Author:  Chen et al.
  Date:  28-Jul-21
  Journal: European Journal of Cancer
   
• Antibody and T cell immune responses following mRNA COVID-19 vaccination in patients with cancer
  Author:  Ehmsen et al.
  Date:  27-Jul-21
  Journal: Cancer Cell
   
• Low rate of seroconversion after mRNA anti-SARS-CoV-2 vaccination in patients with hematological malignancies
  Author:  Re et al.
  Date:  26-Jul-21
  Journal: Leukemia & Lymphoma
   
• COVID-19 vaccination for cancer patients: Evidence, priority, and practice
  Author:  Rajan et al.
  Date:  24-Jul-21
  Journal: Vaccine
   
• Adapting cancer civil society organizations to accelerate COVID-19 vaccinations in people living with cancer in low- and middle-income countries—A commentary
  Author:  Munisamy et al.
  Date:  22-Jul-21
  Journal: JCO Global Oncology
   
• Incidence of axillary adenopathy in breast imaging after COVID-19 vaccination
  Author:  Robinson et al.
  Date:  22-Jul-21
  Journal: JAMA Oncology
   
• Refusal of anti-COVID-19 vaccination in cancer patients: is there a difference between the sexes?
  Author:  Stoekle et al.
  Date:  21-Jul-21
  Journal: European Journal of Cancer
   
• Antibody response to SARS-CoV-2 vaccines in patients with hematologic malignancies
  Author:  Greenberger et al.
  Date:  21-Jul-21
  Journal: Cancer Cell
   
• Cancer patients and internal medicine patients attitude towards COVID-19 vaccination in Poland
  Author:  Kufel-Grabowska et al.
  Date:  20-Jul-21
  Journal: Advances in Clinical and Experimental Medicine
   
• Understanding COVID-19 vaccine hesitancy and resistance: Another challenge in cancer patients
  Author:  Mejri et al.
  Date:  19-Jul-21
  Journal: Supportive Care in Cancer 
   
• COVID-19 vaccine safety in cancer patients: A single centre experience
  Author:  So et al.
  Date:  16-Jul-21
  Journal: Cancers
   
• SARS-CoV-2 vaccination for adolescents and young adult patients treated at a specialist pediatric oncology unit
  Author:  Nigro et al.
  Date:  15-Jul-21
  Journal: Pediatric Blood & Cancer
   
• Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report
  Author:  Cuneo et al.
  Date:  13-Jul-21
  Journal: Hematological Oncology
   
• Pfizer-BioNTech and Oxford AstraZeneca COVID-19 vaccine effectiveness and immune response among individuals in clinical risk groups
  Author:  Whitaker et al.
  Date:  09-Jul-21
  Journal: n/a
   
• COVID-19 vaccination in oncology patients receiving chemotherapy
  Author:  Mungmungpuntipantipa and Wiwanitkit.
  Date:  09-Jul-21
  Journal: Clinical Oncology
   
• Vaccination of cancer patients against COVID-19: Towards the end of a dilemma
  Author:  Mandal et al.
  Date:  08-Jul-21
  Journal: Medical Oncology
   
• Serologic status and toxic effects of the SARS-CoV-2 BNT162b2 vaccine in patients undergoing treatment for cancer
  Author:  Goshen-Lago et al.
  Date:  08-Jul-21
  Journal: JAMA Oncology
   
• Immunogenicity of COVID-19 vaccination in immunocompromised patients: An observational, prospective cohort study interim analysis
  Author:  Haidar et al.
  Date:  30-Jun-21
  Journal: medRxiv
   
• Indications for and contraindications of immune checkpoint inhibitors in cancer patients with coronavirus disease 2019 vaccination
  Author: Luo et al.
  Date:  30-Jun-21
  Journal: Future Oncology
   
• COVID-19 vaccine hesitancy among adolescent and young adult cancer survivors
  Author:  Waters et al.
  Date:  29-Jun-21
  Journal: JNCI Cancer Spectrum
   
• Highly variable SARS-CoV-2 spike antibody responses to two doses of COVID-19 RNA vaccination in patients with multiple myeloma
  Author:  Van Oekelen et al.
  Date:  28-Jun-21
  Journal: Cancer Cell
   
• Covid-19 vaccine mimics lymph node metastases in patients undergoing skin cancer follow-up - a monocenter study
  Author:  Placke et al.
  Date:  26-Jun-21
  Journal: European Journal of Cancer
   
• COVID-19 vaccine development from the perspective of cancer patients
  Author:  He et al.
  Date:  25-Jun-21
  Journal: Human Vaccines & Immunotherapeutics 
   
• BNT162b2 mRNA Covid-19 Vaccine in AYA with cancer: A monocentric experience
  Author:  Revon-Riviere et al.
  Date:  23-Jun-21
  Journal: European Journal of Cancer
   
• COVID-19 vaccination and breast cancer surgery timing
  Author:  Ko et al.
  Date:  22-Jun-21
  Journal: Breast Cancer Research and Treatment
   
• COVID-19 vaccination in patients on rituximab: A survey of lymphoma physicians at NCI designated cancer centers
  Author:  Messmer and Wagner-Johnston.
  Date:  21-Jun-21
  Journal: Leukemia & Lymphoma 
   
• Current perspectives for SARS-CoV-2 vaccination efficacy improvement in patients with active treatment against cancer
  Author:  Barrière et al.
  Date:  18-Jun-21
  Journal: European Journal of Cancer
   
• Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer
  Author:  Addeo et al.
  Date:  18-Jun-21
  Journal: Cancer Cell
   
• Emerging issues related to COVID-19 vaccination in patients with cancer
  Author:  Saini et al.
  Date:  16-Jun-21
  Journal: Oncology and Therapy
   
• Impaired antibody response to COVID-19 vaccination in patients with chronic myeloid neoplasms
  Author:  Chowdhury et al.
  Date:  16-Jun-21
  Journal: British Journal of Haematology
   
• Serological response to COVID-19 vaccination in patients with cancer older than 80 years
  Author:  Iacano et al.
  Date:  11-Jun-21
  Journal: Journal of Geriatric Oncology
   
• Implications of mRNA-based SARS-CoV-2 vaccination for cancer patients
  Author:  Romano et al.
  Date:  11-Jun-21
  Journal: Journal for ImmunoTherapy of Cancer
   
• High levels of anti-SARS-CoV-2 IgG antibodies in previously infected cancer patients after a single dose of BNT 162b2 vaccine
  Author:  Fong et al.
  Date:  11-Jun-21
  Journal: European Journal of Cancer
   
• Attitudes and factors associated with COVID-19 vaccine hesitancy among patients with breast cancer
  Author:  Villarreal-Garza et al.
  Date:  10-Jun-21
  Journal: JAMA Oncology
   
• COVID-19 vaccination in patients with Classic Kaposi’s sarcoma
  Author:  Indini et al.
  Date:  10-Jun-21
  Journal: Vaccines
   
• Association of COVID-19 mRNA vaccine with ipsilateral axillary lymph node reactivity on imaging
  Author:  Emin et al.
  Date:  10-Jun-21
  Journal: JAMA Oncology
   
• COVID-19 vaccination among minority Cancer Patients: Recommendation of the International Geriatric Radiotherapy group
  Author:  Nguyen et al.
  Date:  07-Jun-21
  Journal: Archives of Clinical and Biomedical Research
   
• Seroconversion rates following COVID-19 vaccination amongst patients with cancer
  Author:  Thakkar et al.
  Date:  05-Jun-21
  Journal: Cancer Cell
   
• COVID-19 vaccines in patients with cancer
  Author:  Trapani and Curigliano.
  Date:  01-Jun-21
  Journal: The Lancet Oncology
   
• COVID-19 vaccination in patients with multiple myeloma: Focus on immune response
  Author:  Ludwig et al.
  Date:  31-May-21
  Journal: American Journal of Hematology
   
• Immune responses to SARS-CoV-2 among patients with cancer
  Author:  Sun et al.
  Date:  28-May-21
  Journal: JAMA Oncology
   
• Evaluation of seropositivity following BNT162b2 messenger RNA vaccination for SARS-CoV-2 in patients undergoing treatment for cancer
  Author:  Massarweh et al.
  Date:  28-May-21
  Journal: JAMA Oncology
   
• Cytokine release syndrome in a patient with colorectal cancer after vaccination with BNT162b2
  Author:  Au et al.
  Date:  26-May-21
  Journal: Nature Medicine
   
• The first report on Covid-19 vaccine refusal by cancer patients in Italy: Early data from a single-institute survey
  Author:  Di Noia et al.
  Date:  26-May-21
  Journal: European Journal of Cancer
   
• Adherence to COVID-19 vaccines in cancer patients: Promote it and make it happen!
  Author:  Curigliano and Eggermont.
  Date:  24-May-21
  Journal: European Journal of Cancer
   
• Fifth-week immunogenicity and safety of anti-SARS-CoV-2 BNT162b2 vaccine in patients with multiple myeloma and myeloproliferative malignancies on active treatment: preliminary data from a single institution
  Author:  Pimpinelli et al.
  Date:  17-May-21
  Journal: Journal of Hematology & Oncology
   
• Immune responses to COVID-19 mRNA vaccines in patients with solid tumors on active, immunosuppressive cancer therapy
  uthor:  Shroff et al.
  Date:  14-May-21
  Journal:  medRxiv
   
• COVID-19 vaccine efficacy in patients with chronic lymphocytic leukemia
  Author:  Roeker et al.
  Date:  13-May-21
  Journal:  Leukemia
   
• COVID-19 vaccines in patients with cancer—A welcome addition, but there is need for optimization
  Author:  Korompoli et al.
  Date:  13-May-21
  Journal:  JAMA Oncology
   
• Coordination and optimization of PET/CT and COVID-19 vaccination; Lessons learned in the early stages of mass vaccination
  Author:  McIntosh et al.
  Date:  11-May-21
  Journal: Cancer Treatment Reviews
   
• COVID-19 vaccines in older adults with cancer: A Young International Society of Geriatric Oncology perspective
  Author:  Loh et al.
  Date:  01-May-21
  Journal: The Lancet Health Longevity
   
• Weak immunogenicity after a single dose of SARS-CoV-2 mRNA vaccine in treated cancer patients
  Author:  Palich et al.
  Date:  29-Apr-21
  Journal: Annals of Oncology
   
• Impaired immunogenicity of BNT162b2 anti SARS-CoV-2 vaccine in patients treated for solid tumors
  Author:  Barrière et al.
  Date:  27-Apr-21
  Journal: Annals of Oncology
   
• Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
  Author:  Monin et al.
  Date:  27-Apr-21
  Journal: The Lancet Oncology
   
• Cancer and COVID-19 vaccines: A complex global picture
  Author:  Yusuf et al.
  Date:  27-Apr-21
  Journal: The Lancet Oncology
   
• The effect of the COVID-19 pandemic on routine adult vaccination in cancer patients
  Author:  Ozdemir et al.
  Date:  23-Apr-21
  Journal: Medical Oncology
   
• Cocooning against COVID‐19: The argument for vaccinating caregivers of patients with cancer
  Author:  Woodfield et al.
  Date:  23-Apr-21
  Journal: American Cancer Society Journals
   
• Cancer patients should be considered as a high risk priority target in the coronavirus disease 2019 vaccination process
  Author:  Souadka et al.
  Date:  20-Apr-21
  Journal: Journal of Surgical Oncology
   
• Reply to letter to editor “Cancer patients should be considered as a high‐risk priority target in the COVID‐19 vaccination process”
  Author:  Rajan et al.
  Date:  20-Apr-21
  Journal: Journal of Surgical Oncology
   
• Response to first vaccination against SARS-CoV-2 in patients with multiple myeloma
  Author:  Bird et al.
  Date:  19-Apr-21
  Journal: The Lancet Haematology
   
• Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia
  Author:  Herishanu et al.
  Date:  16-Apr-21
  Journal: Blood
   
• COVID-19 vaccine hesitancy among individuals with cancer, autoimmune diseases, and other serious comorbid conditions
  Author:  Tsai et al.
  Date:  09-Apr-21
  Journal: medRxiv
   
• Short-term safety of the BNT162b2 mRNA COVID-19 vaccine in patients with cancer treated with immune checkpoint inhibitors
  Author:  Waissengrin et al.
  Date:  01-Apr-21
  Journal: The Lancet Oncology
   
• SARS-CoV-2 vaccination for patients with solid cancer: Review and point of view of a French oncology inter-group (CGO, TNCD, UNICANCER)
  Author:  Tougeron et al.
  Date:  01-Apr-21
  Journal: European Journal of Cancer
   
• Study of the SARS-CoV-2-specific immune T-cell responses in COVID-19-positive cancer patients
  Author:  Mansi et al.
  Date:  26-Mar-21
  Journal: European Journal of Cancer
   
• Vaccine enthusiasm and hesitancy in cancer patients and the impact of a webinar
  Author:  Kelkar et al.
  Date:  25-Mar-21
  Journal: Healthcare
   
• COVID-19 infection in cancer patients: what has been the contribution of Associazione Italiana Oncologia Medica (AIOM) to oncological care since the beginning of the first pandemic wave?
  Author:  Silvestris et al.
  Date:  17-Mar-21
  Journal: ESMO Open
   
• Interim results of the safety and immune-efficacy of 1 versus 2 doses of COVID-19 vaccine BNT162b2 for cancer patients in the context of the UK vaccine priority guidelines
  Author:  Monin-Aldama et al.
  Date:  17-Mar-21
  Journal: medRxiv
   
• COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials
  Author:  Desai et al.
  Date:  15-Mar-21
  Journal: Nature Reviews Clinical Oncology
   
• COVID-19 vaccine hesitancy among blood cancer patients
  Author:  Conti et al.
  Date:  08-Mar-21
  Journal: Leukemia & Lymphoma Society
   
• Delaying second vaccine dose leaves cancer patients vulnerable to virus
  Author:  Irshad et al.
  Date:  11-Mar-21
  Journal: n/a
   
• COVID-19 vaccine prioritisation for medical students: The forgotten cohort?
  Author:  Lim et al.
  Date:  02-Mar-21
  Journal: Clincal Oncology
   
• Hurrying up but not rushing, acting and not reacting, good sense and not common sense: Open thoughts and reasonable doubts on COVID-19 vaccination strategies in cancer patients
  Author: Loupakis et al.
  Date:  26-Feb-21
  Journal: Critical Reviews in Oncology/Hematology
   
• COVID-19 vaccines for patients with cancer: Benefits likely outweigh risks
  Author:  Hwang et al.
  Date:  26-Feb-21
  Journal: Journal of Hematology & Oncology 
   
• Current perspectives: SARS-CoV-2 vaccines for cancer patients: A call to action
  Author:  Corti et al.
  Date:  24-Feb-21
  Journal: European Journal of Cancer
   
• Lymphadenopathy in COVID-19 vaccine recipients: Diagnostic dilemma in oncology patients
  Author:  Özütemiz et al.
  Date:  24-Feb-21
  Journal: Radiology
   
• SARS-CoV-2 vaccines in patients with multiple myeloma
  Author:  Gavriatopoulou et al
  Date:  17-Feb-21
  Journal: Hemasphere
   
• COVID-19 vaccination: The VOICE for patients with cancer
  Author:  van der Veldt et al.
  Date:  15-Feb-21
  Journal: Nature Medicine
   
• The ESMO Call to Action on COVID-19 vaccinations and patients with cancer: Vaccinate. Monitor. Educate
  Author:  Garassino et al.
  Date:  11-Feb-21
  Journal: Annals of Oncology
   
• SARS-CoV-2 vaccination and phase 1 cancer clinical trials
  Author:  Yap et al.
  Date:  08-Feb-21
  Journal: The Lancet Oncology
   
• COVID vaccination in cancer patients: What vaccination priority strategies should there be?
  Author:  Silvestris et al.
  Date:  04-Feb-21
  Journal: Frontiers in Oncology
   
• Challenges and opportunities for COVID-19 vaccines in patients with cancer
  Author:  Kuderer et al.
  Date:  03-Feb-21
  Journal: Cancer Investigation
   
• Professionally responsible COVID-19 vaccination counseling of obstetric/gynecologic patients: Counseling patients about COVID-19 vaccination
  Author: Chervenak et al.
  Date:  01-Feb-21
  Journal:  American Journal of Obstetrics and Gynecology
   
• COVID-19, the future vaccine and what it means for cancer patients on immunotherapy
  Author:  El-Shakankery et al.
  Date:  01-Feb-21
  Journal: Frontiers in Oncology
   
• Acceptance of SARS-CoV-2 vaccination among French patients with cancer: a cross-sectional survey
  Author:  Barriere et al.
  Date:  29-Jan-21
  Journal: Annals of Oncology
   
• COVID-19 vaccines: Preparing for vaccination in the context of clinical oncology care
  Author:  Carr et al.
  Date:  22-Jan-21
  Journal: Clinical Journal of Oncology Nursing
   
• COVID-19 vaccine race: Watch your step for cancer patients
  Author:  Fanciullino et al.
  Date:  07-Dec-20
  Journal: British Journal of Cancer